OH HB276

Drug manufacturers, repackagers, and third-party logistics providers are prohibited from denying, restricting, or discriminating against 340B covered entities in acquiring or receiving 340B drugs, unless prohibited by federal HHS

Drug manufacturers cannot require 340B grantees to submit claims or utilization data as a condition for obtaining 340B drugs, unless required by federal HHS

Violations constitute unfair and deceptive insurance practices, with civil penalties of $50,000 per violation up to $10 million annually, with each drug package considered a separate violation

The Superintendent of Insurance may refer violations to the State Board of Pharmacy for additional sanctions against licensees

The bill adds definitions for "340B drug pricing program," "manufacturer of dangerous drugs," "repackager of dangerous drugs," and "third-party logistics provider" to existing insurance code provisions